USD 155.79 million
Report ID:
SQMIG35A2983 |
Region:
Global |
Published Date: February, 2025
Pages:
221
|Tables:
87
|Figures:
76
Global Exosome Research Products Market size was valued at USD 155.79 million in 2023 and is poised to grow from USD 180.56 million in 2024 to USD 587.88 million by 2032, growing at a CAGR of 15.9% during the forecast period (2025-2032).
Academic research institutes, pharmaceutical and biotechnology, hospitals, and clinical trials are the end users of this market. Demand for exosome studies has increased in recent years for many academic researchers due to their diagnostic abilities and emerging role as intercellular messengers. They attracted interest, driving the growth of the market. More than 6,000 substances are currently being tested in clinical trials worldwide, representing a 68% increase, according to pharmaceutical research and development spending in 2022.
According to WHO, cancer is a leading cause of death worldwide, with nearly 10 million deaths by 2020. The number of cancer cases in India is about 679,421 among men and about 712,758 among women a year 2020. The number of new cancer cases and deaths in 2021 is approximately 1.9 million, with 608,570 cancer deaths in the United States. Thus, the occurrence of cancer encourages researchers to do more research, and biomarkers help in identifying cancer. Thus, market growth increases.
Thus, in conclusion, the increasing number of chronic diseases such as cardiovascular diseases, rheumatoid arthritis, and other chronic diseases has increased the demand for various pharmaceutical drugs and will drive global demand the exosome research products market has grown in the coming years.
Market snapshot - 2025-2032
Global Market Size
USD 155.79 million
Largest Segment
Cancer
Fastest Growth
Infectious Diseases
Growth Rate
15.9% CAGR
To get more reports on the above market click here to Buy The Report
Global Exosome Research Products Market is segmented by Product, Indication, Application, Manufacturing Service, End User and region. Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Indication, the market is segmented into Cancer Indication, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases and Other Diseases. Based on Application, the market is segmented into Biomarkers, Vaccine Development, Tissue Regeneration and Other applications. Based on Manufacturing Service, the market is segmented into Stem cell-derived exosome manufacturing services, Dendritic cell-derived exosome manufacturing services and Other manufacturing services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Hospitals & Clinical Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The kits and reagents are the dominating segment. Key players are launching new kits and reagents to expand exosome applications, for example ExoRelease for exosome isolation and purification by Clara Biotech made in May 2022. Such technological advances help researchers to find new biomarkers to screen and refine exosome-based therapeutic and diagnostic applications and hence such advances are expected to drive segment growth in the coming years.
The services segment is expected to register rapid growth during the forecast years. Isolation of exosomes can be a complex, nonspecific, and tedious process. Thus, end-users outsource isolation, characterization, and clinical progress to reduce turnaround time. Several third parties in the industry offer exosome services. For example, AMSBIO, a US-based company, offers services, such as exosome isolation & quantification, exosome miRNA isolation & sequencing, exosome backmarking analysis and proteomics services and thus a wide range of companies are expected to provide that this section has continued.
The cancer segment accounted for the largest market share of 31.88% by 2022. This can be attributed to the widespread use of exosomes in cancer diagnosis, prognosis and therapy. Exosomes can be used for delivery of RNA, small molecules and proteins to treat disease to target cancer cells with high efficiency. In addition, lipids, proteins, and nucleic acids transported by exosomes are being investigated as potential targets for cancer therapy and promising biomarkers for cancer diagnosis and prognosis.
The infectious diseases segment is expected to expand at a rapid CAGR during the forecast period. Exosomes are known to be involved in many infectious diseases. The ability of epithelial cells to transport molecules to distal or remote locations, allowing them to mediate biological functions, is a key characteristic of such tissues. Such access may be provided have been used to develop vaccines and other therapeutic strategies. All these factors can help generate revenue in this segment.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the market as increasing R&D investments are expected to drive the market growth. Large players such as Hologic Inc., Luminex Corporation and Thermo Fisher Scientific have a strong presence in the North American region. North America plays an important role in the growth of the global exosome research products market. With a network of leading research institutes, biotech companies, and funds actively involved in exosome research in North America, particularly in the United States, the region benefits from an internal ecosystem is a strong supporter of scientific innovation, technological development and commercialization efforts in the field of exosome biology. North America is expected to be dominated by major market players having a large consumer market with high GDP. It is expected that the U.S. will grow due to increasing technological advances in exosome sensing materials.
Asia Pacific is the fastest growing segment in the market. In Asia Pacific, countries such as China, Japan and South Korea are making rapid progress in exosome research and technology development. The region's growing investments in life science research, biotechnology infrastructure, academic and industrial collaborations create favorable conditions for exosome research products market growth. Furthermore, large patient availability, rising healthcare costs and drug an increased demand for precision solutions.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Interest in Extracellular Vesicle Research
Technological Advancements
Complexity and Heterogeneity of Exosomes
Regulatory and Ethical Considerations
Request Free Customization of this report to help us to meet your business objectives.
Global exosome research products market is highly competitive and consists of a number of major players. Key players are focusing on stretegic partnership to improve their product offerings. In October 2022, FUJIFILM Diosynth Biotechnologies strategically partnered with RoosterBio to develop GMP-compliant exosome and cell therapies.
Rising Adoption of Advanced Isolation
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global exosome research products market is growing rapidly with increasing research interest in extracellular vesicles, technological advances in isolation and analysis methods, and potential applications in diagnostics and therapeutics. Despite challenges related to exosome heterogeneity and regulation theory, the market is poised for expansion with continuous innovation and investments in exosome-related products and services. North America and Asia Pacific are the major growth regions of the market, benefiting from explore the complexity of biological systems and the increasing demand for exosome analysis solutions.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 155.79 million |
Market size value in 2032 | USD 587.88 million |
Growth Rate | 15.9% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Exosome Research Products Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Exosome Research Products Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Exosome Research Products Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Exosome Research Products Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Exosome Research Products Market size was valued at USD 325.79 Million in 2023 and is poised to grow from USD 423.2 Million in 2024 to USD 3430.98 Million by 2032, growing at a CAGR of 29.9% during the forecast period (2025-2032).
Global exosome research products market is highly competitive and consists of a number of major players. Key players are focusing on stretegic partnership to improve their product offerings. In October 2022, FUJIFILM Diosynth Biotechnologies strategically partnered with RoosterBio to develop GMP-compliant exosome and cell therapies.Top Player’s Company Profiles 'Thermo Fisher Scientific Inc.', 'QIAGEN N.V.', 'NanoSomiX Inc.', 'System Biosciences LLC', 'Malvern Instruments Ltd.', 'Bio-Techne Corporation', 'Norgen Biotek Corp.', 'Lonza Group Ltd.', 'HansaBioMed Life Sciences Ltd.', 'AMS Biotechnology (Europe) Ltd.', 'Hitachi Chemical Co. Ltd.', 'Evomic Science LLC', 'Codiak Biosciences Inc.', 'Exosome Diagnostics Inc.', 'Aethlon Medical Inc.', 'Evox Therapeutics Ltd.', 'Jazz Pharmaceuticals plc', 'ReNeuron Group plc', 'Capricor Therapeutics Inc.', 'Stem Cells Inc.'
The increasing reputation of the significance of exosomes in intercellular verbal exchange, biomarker discovery, and disease pathogenesis is using research hobby in exosome-related merchandise. Researchers are exploring exosomes' ability packages in diagnostics, therapeutics, and drug shipping, fueling call for exosome research merchandise.
One key marketplace trend within the global exosome research products market is the growing adoption of advanced isolation and analysis technologies. Researchers are in search of progressive strategies and tools for setting apart exosomes from complicated biological samples, together with blood, urine, and tissue fluids, with high purity and yield. Additionally, there's a developing call for integrated structures that enable comprehensive characterization and useful analysis of exosomes, including their shipment molecules, surface markers, and biological sports.
North America dominated the market as increasing R&D investments are expected to drive the market growth. Large players such as Hologic Inc., Luminex Corporation and Thermo Fisher Scientific have a strong presence in the North American region. North America plays an important role in the growth of the global exosome research products market. With a network of leading research institutes, biotech companies, and funds actively involved in exosome research in North America, particularly in the United States, the region benefits from an internal ecosystem is a strong supporter of scientific innovation, technological development and commercialization efforts in the field of exosome biology. North America is expected to be dominated by major market players having a large consumer market with high GDP. It is expected that the U.S. will grow due to increasing technological advances in exosome sensing materials.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2983
[email protected]
USA +1 351-333-4748